These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16940696)

  • 1. [Pharmacological properties of a specific Gq/11 inhibitor, YM-254890].
    Kawasaki T; Uemura T; Taniguchi M; Takasaki J
    Nihon Yakurigaku Zasshi; 2006 Jul; 128(1):23-31. PubMed ID: 16940696
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Activity Relationship Studies of the Cyclic Depsipeptide Natural Product YM-254890, Targeting the G
    Zhang H; Xiong XF; Boesgaard MW; Underwood CR; Bräuner-Osborne H; Strømgaard K
    ChemMedChem; 2017 Jun; 12(11):830-834. PubMed ID: 28509439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic and thrombolytic efficacy of YM-254890, a G q/11 inhibitor, in a rat model of arterial thrombosis.
    Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Nagai K; Inagaki O; Shikama H
    Thromb Haemost; 2003 Sep; 90(3):406-13. PubMed ID: 12958608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of YM-254890, a specific G(alpha)q/11 inhibitor, on thrombosis and neointima formation in mice.
    Kawasaki T; Taniguchi M; Moritani Y; Uemura T; Shigenaga T; Takamatsu H; Hayashi K; Takasaki J; Saito T; Nagai K
    Thromb Haemost; 2005 Jul; 94(1):184-92. PubMed ID: 16113802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats.
    Uemura T; Takamatsu H; Kawasaki T; Taniguchi M; Yamamoto E; Tomura Y; Uchida W; Miyata K
    Eur J Pharmacol; 2006 Apr; 536(1-2):154-61. PubMed ID: 16566917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationship Studies of the Natural Product G
    Xiong XF; Zhang H; Boesgaard MW; Underwood CR; Bräuner-Osborne H; Strømgaard K
    ChemMedChem; 2019 Apr; 14(8):865-870. PubMed ID: 30790465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YM-254890 analogues, novel cyclic depsipeptides with Galpha(q/11) inhibitory activity from Chromobacterium sp. QS3666.
    Taniguchi M; Suzumura K; Nagai K; Kawasaki T; Takasaki J; Sekiguchi M; Moritani Y; Saito T; Hayashi K; Fujita S; Tsukamoto S; Suzuki K
    Bioorg Med Chem; 2004 Jun; 12(12):3125-33. PubMed ID: 15158780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G
    Meleka MM; Edwards AJ; Xia J; Dahlen SA; Mohanty I; Medcalf M; Aggarwal S; Moeller KD; Mortensen OV; Osei-Owusu P
    Pharmacol Res; 2019 Mar; 141():264-275. PubMed ID: 30634050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship and conformational studies of the natural product cyclic depsipeptides YM-254890 and FR900359.
    Zhang H; Nielsen AL; Boesgaard MW; Harpsøe K; Daly NL; Xiong XF; Underwood CR; Haugaard-Kedström LM; Bräuner-Osborne H; Gloriam DE; Strømgaard K
    Eur J Med Chem; 2018 Aug; 156():847-860. PubMed ID: 30055466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of UBO-QIC as a Gαq inhibitor in platelets.
    Inamdar V; Patel A; Manne BK; Dangelmaier C; Kunapuli SP
    Platelets; 2015; 26(8):771-8. PubMed ID: 25734215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule.
    Nishimura A; Kitano K; Takasaki J; Taniguchi M; Mizuno N; Tago K; Hakoshima T; Itoh H
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13666-71. PubMed ID: 20639466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering Specificity Determinants for FR900359-Derived G
    Reher R; Kühl T; Annala S; Benkel T; Kaufmann D; Nubbemeyer B; Odhiambo JP; Heimer P; Bäuml CA; Kehraus S; Crüsemann M; Kostenis E; Tietze D; König GM; Imhof D
    ChemMedChem; 2018 Aug; 13(16):1634-1643. PubMed ID: 29873888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling binding mechanism and kinetics of macrocyclic Gα
    Voss JH; Nagel J; Rafehi M; Guixà-González R; Malfacini D; Patt J; Kehraus S; Inoue A; König GM; Kostenis E; Deupi X; Namasivayam V; Müller CE
    Pharmacol Res; 2021 Nov; 173():105880. PubMed ID: 34506902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.
    Xiong XF; Zhang H; Underwood CR; Harpsøe K; Gardella TJ; Wöldike MF; Mannstadt M; Gloriam DE; Bräuner-Osborne H; Strømgaard K
    Nat Chem; 2016 Nov; 8(11):1035-1041. PubMed ID: 27768111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ga
    Kamato D; Mitra P; Davis F; Osman N; Chaplin R; Cabot PJ; Afroz R; Thomas W; Zheng W; Kaur H; Brimble M; Little PJ
    Cell Mol Life Sci; 2017 Apr; 74(8):1379-1390. PubMed ID: 27815595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity.
    Malfacini D; Patt J; Annala S; Harpsøe K; Eryilmaz F; Reher R; Crüsemann M; Hanke W; Zhang H; Tietze D; Gloriam DE; Bräuner-Osborne H; Strømgaard K; König GM; Inoue A; Gomeza J; Kostenis E
    J Biol Chem; 2019 Apr; 294(15):5747-5758. PubMed ID: 30745359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic suppression of ATP-sensitive K
    Wang B; Murakami Y; Ono M; Fujikawa S; Matsuyama H; Unno T; Naitou K; Tanahashi Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G618-G630. PubMed ID: 30001145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ric-8A potentiates Gq-mediated signal transduction by acting downstream of G protein-coupled receptor in intact cells.
    Nishimura A; Okamoto M; Sugawara Y; Mizuno N; Yamauchi J; Itoh H
    Genes Cells; 2006 May; 11(5):487-98. PubMed ID: 16629901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
    Latallo ZS; Lopaciuk S
    Thromb Diath Haemorrh Suppl; 1973; 56():253-64. PubMed ID: 4617332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.